1. Home
  2. WABC vs CRVS Comparison

WABC vs CRVS Comparison

Compare WABC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

HOLD

Current Price

$55.81

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.69

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WABC
CRVS
Founded
1972
2014
Country
United States
United States
Employees
627
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
WABC
CRVS
Price
$55.81
$11.69
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$54.00
$30.17
AVG Volume (30 Days)
131.9K
1.6M
Earning Date
04-16-2026
05-07-2026
Dividend Yield
3.35%
N/A
EPS Growth
N/A
48.04
EPS
3.40
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.93
$3.55
52 Week High
$56.36
$26.95

Technical Indicators

Market Signals
Indicator
WABC
CRVS
Relative Strength Index (RSI) 61.05 35.33
Support Level $46.73 $11.42
Resistance Level $56.11 $19.21
Average True Range (ATR) 1.02 0.97
MACD 0.01 -0.12
Stochastic Oscillator 81.03 4.66

Price Performance

Historical Comparison
WABC
CRVS

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: